tm logo
Trademark Search
AOBIOME THERAPEUTICS

View On IC.GC.CA

AOBIOME THERAPEUTICS
REGISTERED

on 26 May 2022

Last Applicant/ Owned by

AOBIOME LLC

One Broadway, 14th floorCambridge, MA 02142

US

Serial Number

1911275 filed on 24th Jul 2018

Registration Number

TMA1130134 registered on 26th May 2022

Registration expiry Date

26th May 2032

Correspondent Address

World Exchange Plaza100 Queen Street, Suite 1300Ottawa

ONTARIO

CA

K1P1J9

AOBIOME THERAPEUTICS

Trademark usage description

topical skin sprays, gels and creams for cosmetic purposes; cosmetic preparations for body care; cosmetic preparations for skin care; pre-moistened co Read More

Classification Information

Class [003]
Topical skin sprays, gels and creams for cosmetic purposes; cosmetic preparations for body care; cosmetic preparations for skin care; pre-moistened cosmetic wipes, towelettes, and tissues; skin fresheners; gels for cosmetic purposes; non-medicated gels for skin care; creams for cosmetic purposes; non-medicated creams for skin care; hair care preparations; hair cleaning preparations; hair shampoos and conditioners.

Classification kind code

11

Class [005]
Medicated gels for therapeutic use namely therapeutic pharmaceuticals containing ammonia oxidizing bacteria for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, and cardiovascular and circulatory disorders, and headaches and migraines, and to counteract skin damage caused by UV exposure and aging; medicated creams for therapeutic use namely therapeutic pharmaceuticals containing ammonia oxidizing bacteria for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, and cardiovascular and circulatory disorders, and headaches and migraines, and to counteract skin damage caused by UV exposure and aging; medicated sprays for therapeutic use namely therapeutic pharmaceuticals containing ammonia oxidizing bacteria for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, and cardiovascular and circulatory disorders, and headaches and migraines, and to counteract skin damage caused by UV exposure and aging; nasal sprays for therapeutic use; topical applications for therapeutic use namely therapeutic pharmaceuticals containing ammonia oxidizing bacteria for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, and cardiovascular and circulatory disorders, and headaches and migraines, and to counteract skin damage caused by UV exposure and aging; medicated liquids for therapeutic use namely therapeutic pharmaceuticals containing ammonia oxidizing bacteria for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, and cardiovascular and circulatory disorders, and headaches and migraines, and to counteract skin damage caused by UV exposure and aging; biological therapeutics for treatment of skin disorders namely inflammatory skin disorders, and skin damage caused by UV exposure and aging, circulatory and cardiovascular disorders, neurological disorders namely headaches, migraines, dementia, and autism, inflammation, gastrointestinal disorders, respiratory disorders, eye disorders, urogenital disorders namely fungal infections, infections and inflammation, auditory disorders, migraines, headaches, allergic rhinitis, insomnia, hyperhidrosis, acne, and hypertension; therapeutic agents for thermoregulation and promoting wound healing.

Classification kind code

11

Class [010]
Stents; intra-uterine devices; catheters; pessaries; coatings namely therapeutic pharmaceuticals containing ammonia oxidizing bacteria sold as an integral component of medical stents and other implantable medical devices.

Classification kind code

11

Mark Details

Serial Number

1911275

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 190
on 08th Dec 2021		Registration Pending
Submitted for opposition 191
on 08th Dec 2021		Registration Fee Notice Sent
Submitted for opposition 42
on 15th Sep 2021		Advertised
Submitted for opposition 26
on 20th Aug 2021		Approved
Submitted for opposition 27
on 20th Aug 2021		Approval Notice Sent
Submitted for opposition 22
on 25th Aug 2020		Search Recorded
Submitted for opposition 20
on 25th Aug 2020		Examiner's First Report
Submitted for opposition 31
on 26th Jul 2018		Formalized
Submitted for opposition 1
on 25th Jul 2018		Created
Submitted for opposition 30
on 24th Jul 2018		Filed